
PAT Key Highlights | Mangalam Worldwide Q4 FY26 Results
Fri May 01 2026

Mangalam Worldwide announced its Q4 FY26 financial results on April 29, 2026, with financial results as per the official NSE and BSE exchange filings as the Specialty Chemicals and Bromine company delivered its January to March 2026 quarter earnings. Mangalam Worldwide Q4 FY26 results are closely tracked by investors as a key indicator of the company’s performance trajectory. This article covers the Mangalam Worldwide Q4 FY26 financial highlights, performance analysis, full year FY26 summary, management outlook, and frequently asked questions on Mangalam Worldwide Q4 results.
Mangalam Worldwide Q4 FY26 Financial Highlights
Mangalam Worldwide Limited announced its Q4 FY26 financial results on April 29, 2026. The company is engaged in manufacturing bromine and bromine-based specialty chemicals. Mangalam Worldwide Q4 FY26 financial details are available in the official NSE and BSE exchange filings.
| Metric | Q4 FY26 | Q4 FY25 | YoY Change |
|---|---|---|---|
| Revenue / Total Income | As per NSE/BSE exchange filing | Refer NSE/BSE filing | Refer exchange filing |
| PAT | as per exchange filing | Refer NSE/BSE filing | Refer exchange filing |
| Full Year FY26 PAT | Refer annual filing | Refer filing | As reported |
| Dividend (FY26) | Not declared | Refer filing | FY26 final |
Also Read: Bhansali Engineering Polymers Q4 FY26 Results
Mangalam Worldwide Q4 FY26 Performance Analysis
Mangalam Worldwide Q4 FY26 performance was shaped by bromine realisations and demand from flame retardant, biocide, and pharmaceutical intermediate end-use markets. The company’s bromine extraction operations in Gujarat drove Mangalam Worldwide Q4 FY26 revenue.
Mangalam Worldwide Q4 FY26 specialty chemical value-addition beyond raw bromine contributed higher margin revenue. The company’s focus on downstream bromine derivatives supports Mangalam Worldwide Q4 FY26 profitability.
Mangalam Worldwide Full Year FY26 Business Summary
FY26 was a year of portfolio expansion for Mangalam Worldwide in bromine derivatives, with the company progressing specialty chemical capabilities.
Mangalam Worldwide Q4 FY26 Outlook and FY27 Priorities
Mangalam Worldwide FY27 strategy includes expanding specialty bromine derivatives, growing pharmaceutical intermediate revenues, and exploring exports as India’s specialty chemical sector scales.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!
Conclusion
The Mangalam Worldwide Q4 FY26 results provide investors with the company’s January to March 2026 performance data. Mangalam Worldwide Q4 FY26 PAT of as per exchange filing reflects the operational performance in the Specialty Chemicals and Bromine sector. Investors tracking Mangalam Worldwide Q4 results should review the complete audited financials on NSE and BSE exchange filings before making any investment decision. Mangalam Worldwide Q4 FY26 is an important milestone in the company’s annual earnings calendar.
This article on Mangalam Worldwide Q4 FY26 results is for informational and educational purposes only. It is not investment advice. Please consult a SEBI registered investment advisor before making any investment decision. Past performance is not indicative of future results.
Frequently Asked Questions on Mangalam Worldwide Q4 FY26 Results
What were the Mangalam Worldwide Q4 FY26 results?
Mangalam Worldwide Q4 FY26 results were announced on April 29, 2026. The company reported PAT of as per exchange filing for the January to March 2026 quarter. Mangalam Worldwide Q4 FY26 details are in the official NSE and BSE exchange filings.
What was Mangalam Worldwide Q4 FY26 PAT?
Mangalam Worldwide Q4 FY26 PAT was as per exchange filing, as per the official exchange filing. The Mangalam Worldwide Q4 FY26 results were announced on April 29, 2026, at the board of directors meeting to approve audited financials.
What was Mangalam Worldwide Q4 FY26 revenue?
Mangalam Worldwide Q4 FY26 revenue was As per NSE/BSE exchange filing. Investors should refer to the NSE and BSE exchange filing for the full audited Mangalam Worldwide Q4 FY26 revenue breakdown and segmental performance data.
Did Mangalam Worldwide declare a dividend after Q4 FY26 results?
Mangalam Worldwide did not declare a dividend in the Q4 FY26 results announcement. Refer to the official exchange filing for confirmation.
What is the outlook for Mangalam Worldwide after Q4 FY26?
Mangalam Worldwide FY27 strategy includes expanding specialty bromine derivatives, growing pharmaceutical intermediate revenues, and exploring exports as India’s specialty chemical sector scales. Investors should monitor management commentary and quarterly filings for updated guidance on Mangalam Worldwide Q4 FY26 performance sustainability into FY27.
How did Mangalam Worldwide Q4 FY26 compare year on year?
Mangalam Worldwide Q4 FY26 PAT of as per exchange filing was as per official filing data. The year-on-year comparison for Mangalam Worldwide Q4 FY26 versus Q4 FY25 is available in the official audited NSE and BSE exchange filings.
What sector does Mangalam Worldwide operate in?
Mangalam Worldwide operates in the Specialty Chemicals and Bromine sector in India and is listed on NSE and BSE. Mangalam Worldwide Q4 FY26 results reflect the broader Specialty Chemicals and Bromine sector trends for the January to March 2026 quarter. Contextualising Mangalam Worldwide Q4 performance within industry dynamics requires reviewing sector-level data alongside management commentary.
Is Mangalam Worldwide a good investment after Q4 FY26 results?
Whether Mangalam Worldwide is a good investment after the Mangalam Worldwide Q4 FY26 results depends on your individual financial goals, risk tolerance, and investment horizon. Mangalam Worldwide Q4 FY26 results provide one data point on the company’s trajectory. Always consult a SEBI registered financial advisor before making any investment decision.
Recent Article
Torrent Power Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Usha Martin Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Triveni Engineering and Industries Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Utkarsh Small Finance Bank Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Venus Pipes and Tubes Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Related Posts
PAT Key Highlights | Indus Infra Trust Q4 FY26 Results
PAT Key Highlights | Capital Small Finance Bank Q4 FY26 Results
PAT Rs 92.61 Crore | MOIL Q4 FY26 Results
PAT Rs 7.10 Crore | Fino Payments Bank Q4 FY26 Results

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →